COSTS-CONSEQUENCES ANALYSIS OF CEFTAROLINE FOSAMIL FOR THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

被引:0
|
作者
Salgado, De Santana C. [1 ]
Holanda, P. [2 ]
Senna, T. [2 ]
Carmo, L. [2 ]
Alexandre, R. F. [2 ]
机构
[1] Pfizer, Santos, SP, Brazil
[2] Pfizer, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
PIN23
引用
收藏
页码:S109 / S109
页数:1
相关论文
共 50 条
  • [1] Ceftaroline fosamil for community-acquired pneumonia
    Pawluk, Shane Ashley
    Wilby, Kyle John
    LANCET INFECTIOUS DISEASES, 2015, 15 (09): : 999 - 999
  • [2] Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE
    Carreno J.J.
    Lodise T.P.
    Infectious Diseases and Therapy, 2014, 3 (2) : 123 - 132
  • [3] Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in Spain
    Torres, Antoni
    Bassetti, Matteo
    Welte, Tobias
    Rivolo, Simone
    Remak, Edit
    Peral, Carmen
    Charbonneau, Claudie
    Hammond, Jennifer
    Ansari, Wajeeha
    Grau, Santiago
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (02) : 148 - 155
  • [4] Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
    Maggiore, Christy
    Vazquez, Jose A.
    Guervil, David J.
    Ramani, Ananthakrishnan
    Jandourek, Alena
    Cole, Phillip
    Friedland, H. David
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 557 - 563
  • [5] Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults
    Welte, Tobias
    Kantecki, Michal
    Stone, Gregory G.
    Hammond, Jennifer
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (04) : 410 - 422
  • [6] Ceftaroline Fosamil For The Treatment Of Community-Acquired Bacterial Pneumonia In The Elderly: Capture Study Experience
    Udeani, G.
    Evans, J.
    Cole, P.
    Smith, A.
    Friedland, H. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Ceftaroline Fosamil for Treatment of Pediatric Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
    Esposito, Susanna
    Carrothers, Timothy J.
    Riccobene, Todd
    Stone, Gregory G.
    Kantecki, Michal
    PEDIATRIC DRUGS, 2021, 23 (06) : 549 - 563
  • [8] Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience
    Ramani, Ananthakrishnan
    Udeani, George
    Evans, John
    Jandourek, Alena
    Cole, Phillip
    Smith, Alexander
    Friedland, H. David
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (04) : 229 - 234
  • [9] A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
    Andrew Cristinacce
    James G. Wright
    Gregory G. Stone
    Jennifer Hammond
    Lynn McFadyen
    Susan Raber
    Infectious Diseases and Therapy, 2019, 8 : 185 - 198
  • [10] A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
    Cristinacce, Andrew
    Wright, James G.
    Stone, Gregory G.
    Hammond, Jennifer
    McFadyen, Lynn
    Raber, Susan
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (02) : 185 - 198